Humabiologics provides human-derived biomaterials, including extracellular matrix products, for applications in regenerative medicine, organoid research, and drug testing. The startup addresses the shortage of high-quality human tissues for researchers by offering affordable, consistent, and versatile biomaterials that enhance the physiological relevance of tissue models.
Funding
$667.4K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Researchers in regenerative medicine, drug testing, and tissue engineering face challenges in sourcing high-quality, consistent, and physiologically relevant human-derived biomaterials. Traditional animal-derived or synthetic materials often lack the complex biological cues necessary for accurate tissue models and reliable experimental results. This can lead to inaccurate data, increased development times, and reduced translational potential.
Solution
Humabiologics addresses the limitations of traditional biomaterials by providing a range of human-derived extracellular matrix (ECM) products, collagens, and gelatin. These biomaterials offer superior physiological relevance for applications in regenerative medicine, organoid research, drug testing, and 2D/3D cell culture. Their products are available in various formats, including lyophilized powders, solutions, and coated cultureware, providing researchers with versatile options to suit their specific experimental needs. By utilizing human-derived materials, Humabiologics enables researchers to create more accurate and predictive tissue models, accelerating the development of new therapies and improving research outcomes.
Target Audience
The primary target audience includes researchers and scientists in academia, pharmaceutical companies, and biotech organizations involved in regenerative medicine, drug discovery, tissue engineering, and basic research.
Features
- Native human-derived ECM available in lyophilized and solution formats
- Human collagen products including Type I, Type II, Type I/III, Type IV, and Type V
- Human gelatin available in lyophilized form with medium and high bloom options
- Methacrylated biomaterials for bioink and bioprinting applications
- Tissue-specific and organ-specific ECM coatings for enhanced cell culture
- Customizable screening plates with native human matrix proteins
- Coated cultureware with human skin collagen Type I for improved cell adhesion